8-K filing — SenesTech, Inc. (SNES)
Filed: 2026-10-15 AccNo: 0001628280-26-065948 Size: 175 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Stocks · News reference
SenesTech shares are trading higher after the company reported preliminary Q3 2026 revenue of approximately $1.1 million, representing approximately 55% growth compared with the Q3 revenue of 2025.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
SenesTech Reports Q34 Preliminary Revenue Of ~$1.1M, Up 55% YoY
SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control and sustainable rodent population management, today announced preliminary revenue results for the third quarter of 2026. The Company plans to release
SenesTech Q2 EPS $(0.35) Beats $(0.36) Estimate, Sales $770.000K Beat $601.500K Estimate